- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 207/34
Total number of patents in this class: 559
10-year publication summary
|
29
|
26
|
30
|
37
|
46
|
30
|
34
|
21
|
22
|
24
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sunshine Lake Pharma Co., Ltd. | 626 |
18 |
| Takeda Pharmaceutical Company Limited | 2712 |
17 |
| Daiichi Sankyo Company, Limited | 1890 |
16 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 775 |
12 |
| Viatris Specialty LLC | 161 |
11 |
| Syngenta Crop Protection AG | 6701 |
9 |
| Eonhf, Inc. | 45 |
7 |
| FUJIFILM Corporation | 30514 |
6 |
| Activesite Pharmaceuticals, Inc. | 17 |
6 |
| Emory University | 1719 |
6 |
| Global Blood Therapeutics, Inc. | 169 |
6 |
| New York Blood Center, Inc. | 169 |
6 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
6 |
| Accent Therapeutics, Inc. | 26 |
6 |
| Aligos Therapeutics, Inc. | 163 |
6 |
| Novartis AG | 10262 |
5 |
| AstraZeneca AB | 2814 |
5 |
| Bayer Cropscience AG | 1844 |
5 |
| Astellas Pharma Inc. | 1044 |
5 |
| Ono Pharmaceutical Co., Ltd. | 421 |
5 |
| Other owners | 396 |